Immunic market cap
Witryna6 kwi 2024 · Immunic to Host Virtual Celiac Disease R&D Day to Highlight Current Pathways for Drug Development and Unmet Medical Need – Conference Call and Webcast to be Held Today, February 9, 2024, at 11:00 am ET – NEW YORK , Feb. 9, 2024 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage … WitrynaChardan Capital Markets: Buy: $40: Show Previous Ratings Apr-13-23 08:00AM: Immunic gets a "positive surprise" from lead asset trial. News Direct. Apr-06-23 02:10PM: Immunic's (IMUX) Ulcerative Colitis Study Shows Positive Data ... Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral …
Immunic market cap
Did you know?
Witryna12 kwi 2024 · Companies. Finance. Industry Witryna23 lut 2024 · NEW YORK, February 23, 2024 - Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small …
WitrynaCurrent and historical revenue charts for Immunic. As of March 2024 Immunic's TTM revenue is of N/A. companies: 7,320 total market cap: $84.507 T. Global ranking; … WitrynaImmunic market cap history and chart from 2013 to 2024. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly …
Witryna3 lis 2024 · Immunic, Inc. Reports Third Quarter 2024 Financial Results and Provides Corporate Update. PR Newswire. November 3, 2024, 3:30 AM · 16 min read. – $72.8 Million in Cash and Cash Equivalents as ... WitrynaAktien, Aktienkurse, Devisenkurse und Währungsrechner, Rohstoffkurse. Informationen rund um die Börse zu Aktie, Fonds und ETFs. Börsenkurse für Optionsscheine und Zertifikate. Aktienanalysen - finanzen.net
WitrynaImmunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing three small molecule …
Witryna13 kwi 2024 · IMMUNIC, INC. : Veränderung des Consensus und Kursziel der Analysten der Aktie IMMUNIC, INC. IMUX US4525EP1011 Nasdaq chinese year sign for 2006WitrynaImmunic started at outperform with $40 stock price target at BMO Capital Jul. 20, 2024 at 8:37 a.m. ET by Tomi Kilgore Immunic started at outperform with $59 stock price target at Wedbush chinese year of the rabbit crafts for kidsWitryna3 lis 2024 · Immunic, Inc. Reports Third Quarter 2024 Financial Results and Provides Corporate Update. News provided by. Immunic, Inc. Nov 03, 2024, 06:30 ET. – $72.8 Million in Cash and Cash Equivalents as ... grangemouth business centreWitrynaMarket Cap-1M Daily Avg. Vol-3Y P/B Range - 52W Range - 3Y P/S Range - 3Y DivYield Range - Company Info. more arrow_right. Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerat... grangemouth boxing clubWitryna1 dzień temu · Immunic Inc CEO Dr. Daniel Vitt speaks to Proactive following the release of data from the maintenance phase of its phase... April 13, 2024 chinese year of tigerWitryna15 kwi 2024 · Stock split history for Immunic (IMUX) Immunic stock (symbol: IMUX) underwent a total of 1 stock split. The stock split occured on April 15th, 2024. ... The … chinese year snake and tiger compatibilityWitrynaCompany information for Immunic Inc USD0.0001 share priceincluding general stock details, key personnel and important dates for your diary. ... Market cap: $78.15 million Shares in issue: 44.40 ... grangemouth businesses